Status:
COMPLETED
DMHI for At-Risk College Students
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Prodromal Symptoms
Psychosis
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if a single-session digital intervention (SPARK Coping) is acceptable, usable, and demonstrates a preliminary signal of efficacy in reducing symptom-related...
Eligibility Criteria
Inclusion
- Symptoms indicating risk for psychosis (a distress score \>= 20 on the Prodromal Questionnaire, Brief \[PQ-B\], per Savill et al., 2018; Early Intervention in Psychiatry and a positive frequency average score \>= 1.47 on the Community Assessment of Psychic Experiences (CAPE-P15), per Jaya et al., 2021 and Bukenaite et al., 2017)
- Residence in the United States
- Currently enrolled in a post-secondary college program at the University of Washington.
Exclusion
- Inconsistent or implausible reporting of symptoms at screening as determined by empirically-determined methods for detecting malingering or inconsistency
- Failure to demonstrate understanding of study details in comprehension screening
Key Trial Info
Start Date :
October 4 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 6 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06608498
Start Date
October 4 2024
End Date
January 6 2025
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Washington
Seattle, Washington, United States, 98195